Matrix metalloproteinases 2, 7, and 9 and tissue inhibitor of metalloproteinases-1 in tumors and serum of patients with ovarian neoplasmsстатья
Информация о цитировании статьи получена из
Web of Science ,
Scopus
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 23 сентября 2021 г.
Авторы:
Gershtein E.S. ,
Levkina N.V. ,
Digayeva M.A. ,
Laktionov K.P. ,
Tereshkina I.V. ,
Kushlinsky N.E.
Журнал:
Bulletin of Experimental Biology and Medicine
Том:
149
Номер:
5
Год издания:
2010
Издательство:
Springer Nature
Местоположение издательства:
Switzerland
Первая страница:
628
Последняя страница:
631
DOI:
10.1007/s10517-010-1010-4
Аннотация:
The content of matrix metalloproteinases 7 and 9 was signifi cantly increased, while the content of metalloproteinase 2 was reduced in ovarian cancer tissue compared to benign tumors. In blood serum from patients with ovarian cancer, the concentrations of matrix metalloproteinases 7 and 9 and their type 1 tissue inhibitor were signifi cantly elevated, while the concentration of matrix metalloproteinase 2 was reduced compared to the corresponding parameters in healthy women. After chemotherapy, tissue and serum concentrations of metalloproteinases and their inhibitor in patients practically returned to normal. A signifi cant positive correlation between serum levels of matrix metalloproteinases 7 and 9 and tissue inhibitor of metalloproteinases-1 in patients with ovarian cancer and the size of primary tumor (ultrasound examination) and a positive correlation between these parameters and the concentration of classical ovarian cancer marker CA-125 were demonstrated. В© 2010 Springer Science+Business Media, Inc.
Добавил в систему:
Герштейн Елена Сергеевна